{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "L858R",
          "alt": "R117H",
          "position": "117"
        },
        "variant_string_id": "LRRK2 L858R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Define the disease mechanism",
          "extracted_paper_info": "The study aims to elucidate the mechanisms underlying LRRK2-induced Parkinson's disease, focusing on the role of LRRK2 in post-translational degradation, which is a key driver of neurodegeneration.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states that higher susceptibility to post-translational degradation than the wild-type LRRK2 is a mechanism linked to neurodegeneration."
        },
        {
          "step_name": "Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper utilizes an enzyme activity assay to assess the protective effect of the LRRK2 mutant against hydrogen peroxide-induced apoptosis.",
          "judgment": "Yes",
          "reasoning": "The paper states the use of this assay to determine the protective effect."
        },
        {
          "step_name": "Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper describes the assay as 'broadly accepted historically', which provides a context for its evaluation.",
          "judgment": "Yes",
          "reasoning": "The paper references that the assay is recognized, thus allowing evaluation."
        },
        {
          "step_name": "Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The assay is performed in triplicate and a wild-type protein control is included.",
          "judgment": "Yes",
          "reasoning": "The paper details control experiments and includes wild type protein controls which strengthens the evidence."
        },
        {
          "step_name": "Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The OddsPath is calculated to quantify the likelihood of this variant contributing to neurodegeneration, based on the findings of the enzyme activity assay.",
          "judgment": "Yes",
          "reasoning": "The OddsPath is calculated which helps measure the likelihood of a pathogenic variant"
        },
        {
          "step_name": "Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Variant controls were used to assess the protective effect against apoptosis, the wild-type protein was also tested.",
          "judgment": "Yes",
          "reasoning": "Variant control is used for evaluation of protective effect."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The higher susceptibility of LRRK2 mutant LRRK2 to intracellular degradation than the wild-type molecule strongly suggests a mechanism involved in the neurodegeneration associated with this LRRK2 mutation, warranting a high consideration for its pathogenic potential."
    }
  ]
}